Intervention group for Lung Cancers

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Princess Margaret Cancer Centre, Toronto, Canada
Lung Cancers+3 More
GAM, exercise, health education - Behavioral
Eligibility
65+
All Sexes
What conditions do you have?
Select

Study Summary

Phase 2 randomized controlled study using a waitlist control group. Study Duration 2.5 years Study Agent/ Intervention/ Procedure Comprehensive Geriatric Assessment and Management (GAM) combined with online chair-based exercise (CBE) and health education for 12 weeks.

Eligible Conditions

  • Lung Cancers
  • Gastro-intestinal Cancer

Treatment Effectiveness

Study Objectives

2 Primary · 9 Secondary · Reporting Duration: 12 weeks

12 weeks
Acceptability of the intervention and the study
Effect intervention on Grip strength
Effect intervention on Life space Mobility
Effect intervention on Physical Activity
Effect intervention on Physical function
Effect intervention on number of self-reported Falls
Effect of the intervention on Fatigue
Effect of the intervention on Quality of life
Effect of the intervention on treatment toxicity
Effect of the intervention on unplanned healthcare utilization
Feasability of the study

Trial Safety

Trial Design

2 Treatment Groups

Waitlist control group
1 of 2
Intervention group
1 of 2
Active Control

60 Total Participants · 2 Treatment Groups

Primary Treatment: Intervention group · No Placebo Group · N/A

Waitlist control groupNoIntervention Group · 1 Intervention: Waitlist control group · Intervention Types:
Intervention group
Behavioral
ActiveComparator Group · 1 Intervention: GAM, exercise, health education · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 12 weeks
Closest Location: Princess Margaret Cancer Centre · Toronto, Canada
Photo of princess margaret cancer centre  1Photo of princess margaret cancer centre  2Photo of princess margaret cancer centre  3
2021First Recorded Clinical Trial
8 TrialsResearching Lung Cancers
176 CompletedClinical Trials

Eligibility Criteria

Age 65+ · All Participants · 10 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have a score of at least 3 on the VES-13.
You are physically inactive (no more than 90 min moderate to vigorous activity per week as per GLTEQ and do not currently meet the recommended physical activity volume of 90 min of aerobic exercise/week).
You are considered safe to participate in the weekly classes as per their treating oncologist.
You have been diagnosed with lung or GI cancer and are being referred for first or second-line chemotherapy or immunotherapy
You are able to communicate in English.\n
You must be aged 18 years and over.\n

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.